Ensuring the safety and efficacy of new drugs, medical devices, and biological products does not end once the treatment is approved or is on the market but extends to the post-marketing phase. Since the overarching goal of all new approvals…
Pharmacovigilance is defined by the World Health Organization (WHO) as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse events or any other drug-related problems.” Drug pharmacovigilance programs form an important part of post-marketing risk…
The global Pharmacovigilance market size is expected to reach $ 11.64 billion by 2026 and it is projected to expand at a CAGR of 13.3 during the coming years. Pharmacovigilance is the science and activities involved in the detection, understanding,…
